Thursday, 2 April 2020

Latest News: Chlorhexidine Gluconate (CHG) Cloth Market Size, Trends and Demand

CHG Wipes Market Overview:
Global CHG Wipes Market has the backup to record a CAGR of 4.40% during the forecast period of 2018 to 2023 to reach USD 13948.89 thousand. These CHG wipes are antiseptic wipes with high amount of Chlorhexidine Gluconate (CHG) mixed in it. The process is to ensure better removal of bacteria and prevention of various infection. Market Research Future (MRFR) has focused well on the Chlorhexidine Gluconate Wipes Market and declared that this growth can be attributed to several factors of which hike in healthcare investment is expected to make better market growth. 
Various clinics and hospitals are launching substantial demand for the CHG Wipes Market due to the global implementation of stringent laws to protect patients from various infections. 
CHG Wipes Market Segmentation:
Global CHG wipes market, upon a consideration of various segments, reveals product type, CHG concentration, application, and distribution channel. These segments portray factors with greater details and open up possibilities of the market understanding. 
By product type, Chlorhexidine Gluconate (CHG) Wipes Market Report can be segmented into CHG bath wipes and CHG/alcohol-based wipes. 
By CHG concentration, the market for for Chlorhexidine Gluconate (CHG) Wipes includes into 2% and 0.5%. 
By application, the global CHG wipes market research includes catheter-associated urinary tract infections, central line-associated bloodstream infection, surgical site infection, and lens cleaners. 
By distribution channel, the for CHG Wipes Market encompasses hospitals & retail pharmacies and online platforms. The hospital and retail pharmacies segment had a valuation of USD 6,407.63 thousand in 2017.
CHG Wipes Market Regional Analysis:
Global CHG Wipes Market Trends, based on a detailed segmentation by MRFR, includes regions like the Americas, Europe, and APAC (Asia-Pacific) where the growth possibility for the market is quite substantial. In the Middle East and Africa region this growth would be a bit slackening due to the presence of several poor economies. 
The Americas can expect substantial growth for the global CHG Wipes market as the healthcare sector in the region is quite extensive and invites high investment. The market gets ample backups from the increase in number of patients who undergo surgical procedure. Disposable income of patients can also inspire better market possibilities. The increasing inclusion of well-developed technology can substantially push the regional market forward. The market has North America and South America of which the North part is performing well. 
Europe market is following the lead of the APAC region and their high healthcare expenditure is boosting the research and development sector. At the same time, CHG Wipes market growth can be backed by the presence of several market players who are devising diverse strategies to gain lead from the market. 
The APAC market can benefit from the changing healthcare sectors in various countries. The high number of patient population in the region can ensure hike in the number of patient population. This region is also the fastest-growing region. Countries like Australia, India, China, Japan, and others are expected to experience substantial growth in the market. 
CHG Wipes Market Competitive Landscape:
Several companies are making substantial changes in the global CHG Wipes Market. These companies try to initiate various moves that can influence personal growth and ensure cementing of their market presence. At the same time, these would also take the market forward by substantial margin. These companies are various 3M (US), Becton, Dickinson and Company (US), GAMA Healthcare Ltd (UK), Cardinal Health (US), PDI Limited (US), Carenow Medical Pvt. Ltd. (India), Pal International (UK), Lernapharm Inc. (Canada), and others. MRFR’s attempt to record their moves is to ensure better market understanding that would highlight trends suitable for the coming years. 
Chlorhexidine Gluconate (CHG) Wipes Industry news
In February 2019, Medline announced a new procedure using which various hospitals and surgical centers can prepare their patients for operations. This pre-operative measure includes patient skin where standardized procedures ensure reduction of surgical site infections (SSIs). The company launched a new FDA-approved ReadyPrepTM CHG cloth. These clothes are pre-saturated and it contains 2 % chlorhexidine gluconate. This is an antiseptic that has the ability to remove infection-causing bacteria. 
Posted by at No comments:
Labels: ,

Global Cardiovascular Application Market Share Dynamics, Trends, Opportunities, Drivers, Challenges

Market Overview:
Rapid advancement in technology is aiding the healthcare sector for the development of high-tech medical devices that can be used to ensure proper functioning of vital organs. Cardiovascular application includes the use of synthetic materials and advanced medical devices to help control abnormal functioning of the heart. Market Research Future (MRFR) has published a report stating that the global cardiovascular application market is market to expand at a notable CAGR of 7.24% during the forecast period of 2014-2023 and reach the valuation of USD 36730.5 Mn by the end of 2023.


Market Drivers and Restraints:
Increasing prevalence of cardiovascular diseases caused due to changing lifestyle and rapid rise in geriatric population are inducing high demand for advanced medical devices, resulting in the significant expansion of the global cardiovascular application market. The introduction of upgraded versions of pacemakers that can be integrated with smartphones to keep a real-time check on the functioning of the heart is impacting positively on the growth of the global cardiovascular application market. However, lack of awareness regarding advanced medical devices, high cost of treatment and medical devices and poor healthcare facilities in the underdeveloped regions are likely to pose potential threat for the growth of the global cardiovascular application market during the forecast period.
Market Segmentation:
The global cardiovascular application market share has been segmented on the basis of devices and end users. Based on devices, the cardiovascular application market has been segmented into cardiac pacemaker, cardiac defibrillators, cardiac monitors, and others. The cardiac monitors segment is sub-segmented into resting ECG, ECG monitors, holter monitors, implantable loop recorder, and others. The cardiac defibrillator segment is sub-segmented into implantable cardioverter defibrillator and external defibrillator. The cardiac pacemaker segment is sub-segmented into implantable cardiac pacemaker and external cardiac pacemaker. The implantable cardiac pacemaker sub-segment includes single-chamber pacemakers, dual-chamber pacemakers, and biventricular pacemakers. 
Based on end users, the cardiovascular application market is segmented into cardiac care centers, ambulatory centers & home care, academic institutes, and others. 
Regional Analysis:
Geographically, the global cardiovascular application market has been segmented into four major regions such as the Americas, Europe, Asia Pacific and the Middle East and Africa. The Americas account for a major market share in the global cardiovascular application market owing to the rapid development of advanced medical devices in the well-developed healthcare sector of this region and increasing incidences suffering from cardiovascular disorders as a result of changing lifestyle. 

The cardiovascular application market in the Europe region is expanding at a noteworthy growth rate due to rise in prevalence of diabetes and cardiovascular diseases and high healthcare expenditure by the population in this region. The Asia Pacific region is projecting fastest growth in the global cardiovascular application market due to the increasing government support for development of affordable treatments and rise in adoption of advanced cardiovascular devices in the emerging economies in this region. The cardiovascular application market is projecting slow growth in the Middle East and Africa region due to the unavailability of proper health care services in the underdeveloped areas of this region.

Industry Updates:
In September 2018, researchers from Duke Clinical Research Institute have collaborated with Cerner, a developer of healthcare solution for the creation of web-based risk calculator application to assist doctors in calculating their patients' risk for atherosclerotic cardiovascular disease (ASCVD).

In September 2018, St. Jude Medical has launched a new diagnosis device named Confirm Loop Recorder. This device is implanted in the body at an angle near the heart in order to monitor abnormal heartbeats in patients with cardiovascular disorders.

In June 2018, a team of cardiologist from Mediclinic Panorama, Cape town have successfully implanted a latest pacemaker technology in an 84-year-old patient. This pacemaker, named 'His Bundle Pacing' (HBP), aids the patient in regaining synchronous contraction of both ventricles like a normal heart, unlike traditional pacemaker.
 Key Players:
Some of the prominent players that are profiled by MRFR in the report on the global cardiovascular application market are Abbott (the U.S.), General Electric Company (the U.S.), Medtronic (Ireland), Boston Scientific Corporation (the U.S.), KONINKLIJKE PHILIPS N.V. (The Netherlands), Terumo (Japan), Stryker Corporation (the U.S.), Edwards Lifesciences (the U.S.), Allergan Inc. (the U.S.), Smith & Nephew plc (the U.K), CR Bard Inc. (the U.S.), Sonova Holdings (Switzerland), and Dragerwerk AG & Co. KGa (Germany)
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:
Labels: ,

Wednesday, 1 April 2020

Barotrauma Market Forecast to Witness a Healthy CAGR Growth of 6.5% by 2023

​Market Highlights
Owing to the increasing cases of ear barotrauma, technological advancements, increasing healthcare expenditure, unmet medical needs, patent expiration of blockbuster drugs, enhancing regulatory framework, increasing government assistance, and rising funding and reimbursement, the barotrauma market has evolved significantly.
However, huge capital investments with low-profit margins, strict FDA regulations, and poor healthcare system in the low and middle-income countries are likely to hamper the growth of the barotrauma market over the forecast period.
It is estimated that the barotrauma market Forecast is expected to have a CAGR of 6.5% during the forecast period of 2017–2023.
Regional Analysis
The Americas dominates the barotrauma market owing to the increasing prevalence of ear barotrauma and high healthcare expenditure.
Europe holds the second position in the barotrauma market. The financial support provided by the government towards R&D and technological advancements are expected to drive the European barotrauma market. The increasing healthcare expenditure is also boosting the European barotrauma market.
According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014, i.e., EUR 321 billion which is further followed by France with EUR 237 billion and United Kingdom with EUR 223 billion. In 2016, the R&D expenditure in the pharmaceutical industry was EUR 35000 million, suggested by the European Federation of Pharmaceutical Industries and Association.
Asia Pacific is the fastest growing barotrauma market owing to a huge patient pool and development in the pharmaceutical sector. Healthcare expenditure is found to be boosting in various regions of Asia Pacific. As per the data suggested by the Australian Institute of Health and Welfare during the year 2015–2016, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014–2015.
The Middle East and Africa holds the lowest share of the global market due to slow development, lack of technical knowledge, and poor medical facilities.
Segmentation
The global barotrauma market is segmented by type, diagnosis, treatment, and end-user.
On the basis of type, the barotrauma market is classified as ear barotrauma, sinus barotrauma, and pulmonary (lung) barotrauma.
On the basis of diagnosis, the barotrauma market is classified as otoscopy, X-ray, Computed Tomography (CT) scan, pulmonary function test, lung perfusion scan, Magnetic Resonance Imaging (MRI), pulse oximetry, and others.
On the basis of treatment, the barotrauma market is classified as pressure relief, medications, surgery, oxygen treatment, recompression therapy, and others. The medications segment is further classified as decongestant nasal sprays, oral decongestants, oral antihistamines, painkillers, antibiotics, and others. The surgery segment is further classified as Functional Endoscopic Sinus Surgery (FESS), tympanostomy, Single Laparoscopic Incision Transabdominal (SLIT), and others.
On the basis of end-user, the barotrauma market is segmented into hospitals and clinics, trauma centers, pharmaceutical companies, medical device companies, academic and research institutes, and others.
Key Players
Some of the key players in the global barotrauma market are 3M, Accurate Surgical & Scientific Instruments Corporation, AptarGroup, AstraZeneca plc., Atos Medical, CellScope, Entellus Medical Inc., GlaxoSmithKline plc, HEINE, Inventis, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Olympus Corporation, Pfizer, Inc., Cipla Ltd., Mylan N.V., Preceptis Medical, Rudolf Riester GmbH, Shanghai Yuejin, SinuSys Corporation, Teva P harmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., Sklar Surgical Instruments, Smith & Nephew Plc, Valeant pharmaceuticals International Inc., Hill-Rom, and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , ,

Tuesday, 31 March 2020

Hammertoe Treatment Market -Research Report, industry Trends and Forecast to 2023

Hammertoe is a feet disorder wherein the feet permanently bends and is caused due to an imbalance in the muscles and the ligaments. It typically occurs while wearing shoes that are narrow or small-sized. In some cases, hammertoe occurs since birth in some individuals. 
According to the recently published report by Market Research Future (MRFR), the global hammertoe treatment market valuation is expected to reach USD 288.61 million by the end of 2023 from its 2018 valuation of USD 172.51 million. The market is forecasted to exhibit a CAGR of 10.8% during the forecast period of 2018 to 2023. 
The growth of the market, according to the report published by MRFR, is attributed to the rising prevalence of arthritis. 
Market Segmentation
The hammertoe market segmentation is classified into four key dynamics: type, end-user, treatment and diagnosis, and region.
By type, the market divides into flexible and rigid segments. It is reported that the rigid segment is anticipated to garner a CAGR of 11.2% during the forecast period. On the other hand, the flexible segment is calculated to register a CAGR of 8.3% during the forecast period.
By treatment, the market includes implant, surgery, and others. While in terms of diagnosis, the market includes physical examinations, x-rays, and others. Among these, the surgery segment is expected to lead the standings in terms of market during the assessment period. 
By end-users, the global market comprises hospitals, clinics, physiotherapy and orthopedic centers, and others. Herein, the hospital segment is anticipated to dominate the global market in the forthcoming years. 
By region, the hammertoe market covers North America, Europe, Asia Pacific, and the Middle East and Africa. 
Regional Analysis 
The regional market is led by North America in terms of market share in the global standings. The region is considered as one of the prime markets for foot and ankle surgery as well. The growth of the region can be attributed to the world-class healthcare infrastructure, rapid adoption of new products and treatments, and advanced medical facilities. With the availability of requisite products and skilled health professionals, and a high power of purchasing, the region is expected to expand in prolific manner in the near future. Moreover, some of the leading players functioning from this region are springing-in new innovation and developments in product to further ameliorate the growth of the market. 
Europe stands second in the global hammertoe market rankings. This is due to the advanced technology here and the fast-paced adoption of new devices. Western European nations like Germany, France, and the UK hold the maximum share of the overall region and contribute heavily to the growth of the regional market.
Asia Pacific is expected to be one of the fastest growing regions due to the fast-paced developing economy, changing healthcare industry, and increasing awareness concerning new products and treatments. Add to this, various profound initiatives have been undertaken by the government to enhance the health of the public. An expanding geriatric population coupled with cases of accidents are likely to propel the market growth in this region in the coming years.
Competitive Landscape
The global hammertoe market includes a number of key and prominent players like Stryker (U.S), BioPro (Michigan), Wright Medical Group N.V. (Memphis, TN), Arrowhead Medical Device Technologies LLC (Tennessee), Smith & Nephew (U.K), Extremity Medical LLC (U.S), Nextremity Solutions Inc. (U.S), and Zimmer Biomet Holdings (U.S).
March 12th, 2019, Nvision Biomedical Technologies’ Vector™ Hammertoe Correction System has been cleared for usage in the US by the Food and Drug Administration of America. It is the first ever ankle and foot implant that is made from advanced, biocompatible PEEK-OPTIMA™ HA Enhanced.
March 3rd, 2019, Centric Medical, a company specializing on developing surgical implants for treating distal extremity pathology, announced in a release the first clinical cases of the SATURN External Fixation System. The system is aimed at being used as a means for stabilizing bone segments for providing indications within the ankle and the foot. 
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: ,

Head Trauma market size Global Insights, Forecast 2020- 2023 - MRFR

Head Trauma Market – Overview
Rise in the number of trauma cases globally especially those of head trauma have prompted an increase in the demand for treatment. Market reports connected with the healthcare industry have been made accessible by Market Research Future who publishes reports on other sectors that have been recently put out along with a report on this industry. The market growth is foreseen to grow with a CAGR of 8.3% over the forecast period. The progress of the market is expected to benefit from the development of new technologies in the upcoming forecast period.
Segmental Analysis
The segmentation of the head trauma market size is segmented on the basis of types, diagnosis, treatment and end users. By types, the market is segmented into haemorrhage and hematoma. By diagnosis, the market is segmented into brain scans, physical examination, and CT scan. By treatment, the market segmentation comprises of anti-seizure drugs, medical treatment, and surgery. By end users, the market is segmented into research institutes and hospitals & clinics.
Detailed Regional Analysis 
The Americas region dominates the market due to the incidence of well-developed technology, growing patient population share with brain disorder, increasing health care spending, and budding government support for research & development. Additionally, intensified R&D activities and the focus of major companies are fuelling the market growth in this region. The European region has the next spot in the market due to the government support for research & development and accessibility of funds for research. This is projected to continue to drive the European market over the forecasted period. The Asia Pacific is showing the fastest growth due to the swiftly evolving healthcare technologies and high healthcare expenditure. Furthermore, the rising patient population in nations like India and South Korea are likely to fortify the market in the forecast period further. Conversely, the Middle East & Africa region controls the least stake in the market due to less accessibility of funds, inadequate medical facilities, and volatile political conditions in the African continent.
Segmentation
The global head trauma market is segmented on the basis of types, diagnosis, treatment, and end user. On the basis of the type, it is segmented into hematoma, and hemorrhage. On the basis of the diagnosis, it is segmented into physical examination, blood test, brain scans, and others. The brain scan is further segmented into computerized tomography (CT) scan, magnetic resonance imaging (MRI) and electroencephalography (EEG). Based on the treatment it is segmented into medical treatment, anti-seizure drugs, surgery, and others. On the basis of the end user, it is segmented into hospitals & clinics, research laboratories, and others.
Key Players
Some of key the players in the market are Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

Posted by at No comments:
Labels:

Hemophilia Treatment Market will Reflecting a CAGR of 6.18% by 2023

Market Overview
The global hemophilia market is forecasted to witness a steady growth of 6.10% during the forecast period between 2018 to 2023. The market valuation is slated to jump from USD 11,257.21 in 2018 to USD 16,059.18 by the end of the forecast period.
The report published by Market Research Future (MRFR) identifies that the prevalence of hemophilia will spring up the demand for hemophilia treatment market globally. The emergence of recombinant products for the treatment of hemophilia has blossomed the interest and demand for the market. The absence of a precise cure and the growing setbacks with the treatment of hemophilia has increased the need for discovering and coming up with new and effective solutions. Gene therapy is increasingly being explored and considered as a permanent solution for hemophilia and offers vast opportunities for the growth of the market.
However, the high cost associated with the treatment and the level of expenses required for consistent lab testing and imaging tests can go on to hamper the market growth of hemophilia treatment. 
Market Segmentation
The global hemophilia treatment market segmentation is based in terms of type, end-user, and treatment.
By type, the market is categorized into hemophilia A, hemophilia B, and hemophilia C. The hemophilia A segment holds the largest share of the global market. The valuation of the segment is expected to reach USD 12.697.99 by the end of the forecast period, 2023. The calculated growth rate of the market annually has been projected to be 6.23% during the forecast period. 
By treatment, the market comprises of recombinant coagulation factor concentrates, plasma-derived coagulation factor concentrates, desmopressin, gene therapy, and antifibrinolytic agents. The recombinant coagulation factor concentrates is the largest market share holder with an expected CAGR of 7.01% during the review period. 
By end-users, the market includes hospitals & clinics, research organization, and others. Hospitals & clinics lead this segmentation of the market and is valued at USD 7594.66 in 2018 and is expected to grow the fastest over the forthcoming years. 
Regional Analysis
The regional segmentation of the hemophilia treatment market covers the following regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. 
The Americas stand tall as the largest market share holder in the global geographical segmentation. This is due to the prevalence of the hemophilia disorder and the presence of a well-established healthcare sector. Growing expenditure in healthcare and increasing support for research and development activities are expected to aid the Americas region to maintain its leadership position. The North American market contributes more to the region than its southern counterpart. 
Europe holds the second biggest market share due to a parallel growth pattern like the Americas. Moreover, government support for R&D activities for advanced medical therapies for hemophilia is another important driver to the market growth in this region. 
Asia Pacific is expected to grow with the highest CAGR of 8.38% during the review period. The healthcare sector in this region is advancing at a rapid pace owing to the high disposable income in the region and expanding advanced medical facilities. The presence of a vast patient population base and a high healthcare expenditure is expected to positively impact the Asia Pacific market growth. 
Competitive Landscape
The global hemophilia treatment market includes various noteworthy players like Baxter, F.Hoffmann-La Roche Ltd, Octapharma, Swedish Orphan Biovitrum AB, Pfizer Inc, CSL Behring, Sanofi, Kedrion, Novo Nordisk A/S, Bayer AG, Grifols International S.A, and Shire.
Feb 19th, 2019, Novo Nordisk announced in a press release about the US FDA approval of N8-GP, turoctocog alfa pegol, to help treat children and adults with hemophilia A in the United States. The therapy will be under the brand name of Esperoct
Feb 7th, 2019, Roche announced its joining with the World Federation of Hemophilia (WFH) Humanitarian Aid Program. The program will see the company treating more than 1,500 people with Hemophilia A across various developing countries.
Read more @ https://www.marketresearchfuture.com/reports/hemophilia-treatment-market-5688
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: ,

Spirometry Market - Growth, Size, Trends

Overview:
The global Spirometry market is witnessing a significant rise in its revenues, mainly due to the rising occurrences of respiratory diseases such as asthma and COPD. Besides, the growing rate of diagnosis processes conducted for the detection of interstitial pulmonary fibrosis fosters the growth of the market. Moreover, the increasing exposure to risk factors and the ever-increasing population is driving a large share of the market.
Market Insights
According to the reports published by Market Research Future Reports, the global Spirometry Market size is probable to exhibit a 10.03% CAGR from 2018 to 2023 and is also on the verge to reach USD 1,106.76 million by 2023. Such a humongous market growth can be attributed to the strident rise in the cases of chronic obstructive pulmonary disorders (COPD) and asthma.
Spirometry is considered as a basic test, which is conducted by clinicians to estimate the status of lungs. It is an essential test for diagnosing asthma, COPD, and other breathing disorders.  Thus, spirometers are used to carry out the tests.
Global Spirometry Market: Drivers & Trends
The factors such as emerging chronic respiratory diseases globally, increasing global aging population, and technological shifts in spirometer devices toward smartphone-based data connectivity and analysis are expected to drive the global spirometry market exponentially during the forecast period. With that, emerging economies with growing industrialization are also contributing to driving the market with opportunities for the future in substantial ways.
More stimulating factors such as government initiatives to restrain smoking habits of people, focus on breathing diseases, rising levels of air pollution, and expanding awareness towards the adoption of spirometers at homes are noticeably auguring the global spirometry market growth. Even awareness of reimbursement policies among the public and clinicians are also projecting to be the drivers for patients towards taking these tests. On the flip side, the high costs of spirometers may act as a restrictive factor against the market and hinder the global spirometry market growth.
Furthermore, the rising geriatric population is also anticipating being the factors for the increase in the demand for spirometers to analyze respiratory patterns. The need for spirometers is also probable in the rise due to a high number of surgeries in hospitals and clinics. These factors are tremendously driving the global spirometry market to rise high at a higher CAGR in the years to come.
Segmental Overview
According to the reports published by MRFR, the global spirometry market has been segmented by product, technology, application, and end-user.
By the mode of products, the market includes table-top spirometry, hand-held spirometry, and desktop (PC) spirometry.
By the mode of technology, the market has been segmented into volume measurement spirometry, peak flow meters (PFM), and flow measurement spirometry.
By the mode of application, the spirometry market is segmented into diagnostic and treatment monitoring.
Moreover, by the mode of end-users, the market includes research & academic institutes, diagnostic centers, hospitals & clinics, and home care.
Regional Outlook
Geographically, the market of spirometry has covered some main regions such as Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
Among these, Asia Pacific is expected to register the highest CAGR for the market to proliferate during the forecast period. Growth of this market in the Asia Pacific region is driven mainly by the large population of the patient and a high prevalence of chronic respiratory diseases.
While North America has the largest market for spirometers owing to technological advancements, government regulations, rise in incidences of respiratory diseases, increasing healthcare expenditure, and improved healthcare infrastructure.
Key Players
In the end, here are the prominent players in the spirometry market, they are Carefusion Corporation (U.S.), NDD Medical Technologies, Inc. (U.S.), Nihon Kohden Corporation (Germany), MGC Diagnostics Corporation (U.S.), Vitalograph (U.K.), Schiller AG (Switzerland), COSMED srl (Italy), Hill-Rom Holdings, Inc. (U.S.), Midmark Corporation (U.S.), Smiths Medical Inc. (U.S.), and Koninklijke Philips N.V. (The Netherlands).
Posted by at No comments:
Subscribe to: Posts (Atom)